These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32346028)

  • 1. Lack of cytomegalovirus (CMV)-specific cell-mediated immune response using QuantiFERON-CMV assay in CMV-seropositive healthy volunteers: fact not artifact.
    Valle-Arroyo J; Aguado R; Páez-Vega A; Pérez AB; González R; Fornés G; Torre-Cisneros J; Cantisán S
    Sci Rep; 2020 Apr; 10(1):7194. PubMed ID: 32346028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients.
    Gabanti E; Lilleri D; Scaramuzzi L; Zelini P; Rampino T; Gerna G
    New Microbiol; 2018 Jul; 41(3):195-202. PubMed ID: 30028473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection.
    Sester M; Sester U; Gärtner BC; Girndt M; Meyerhans A; Köhler H
    J Am Soc Nephrol; 2002 Oct; 13(10):2577-84. PubMed ID: 12239248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMV antigen-specific CD4+ and CD8+ T cell IFNgamma expression and proliferation responses in healthy CMV-seropositive individuals.
    Sinclair E; Black D; Epling CL; Carvidi A; Josefowicz SZ; Bredt BM; Jacobson MA
    Viral Immunol; 2004; 17(3):445-54. PubMed ID: 15357911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
    Fleming T; Dunne J; Crowley B
    J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients.
    Banas B; Böger CA; Lückhoff G; Krüger B; Barabas S; Batzilla J; Schemmerer M; Köstler J; Bendfeldt H; Rascle A; Wagner R; Deml L; Leicht J; Krämer BK
    BMC Immunol; 2017 Mar; 18(1):15. PubMed ID: 28270092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-γ production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients.
    Castón JJ; Cantisán S; González-Gasca F; Páez-Vega A; Abdel-Hadi H; Illescas S; Alonso G; Torre-Cisneros J
    Intensive Care Med; 2016 Jan; 42(1):46-53. PubMed ID: 26537489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of evidence of association between IFNG and IL28B polymorphisms and QuantiFERON-CMV test results in seropositive transplant patients.
    Aguado R; Páez-Vega A; Agüera ML; Montejo M; Guirado L; Fortún J; Suárez-Benjumea A; Len O; Fariñas MC; de Gracia C; Hernández D; Cobos-Ceballos MJ; Torre-Cisneros J; Cantisán S; ;
    Hum Immunol; 2018 Jun; 79(6):499-505. PubMed ID: 29605690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral/Cellular Immune Discordance in Stem Cell Donors: Impact on Cytomegalovirus-Specific Immune Reconstitution after Related Hematopoietic Transplantation.
    Valle-Arroyo J; Páez-Vega A; Fernández-Moreno R; López-Jiménez J; Luna A; Duarte R; Serrano-Martínez F; Villar S; Fernández-Alonso M; Reina G; González-Rico C; Fariñas MC; Rojas R; Herrera C; Martín C; García-Torres E; Torre-Cisneros J; Cantisán S
    Transplant Cell Ther; 2022 Oct; 28(10):703.e1-703.e8. PubMed ID: 35830929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.
    Barabas S; Spindler T; Kiener R; Tonar C; Lugner T; Batzilla J; Bendfeldt H; Rascle A; Asbach B; Wagner R; Deml L
    BMC Immunol; 2017 Mar; 18(1):14. PubMed ID: 28270111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS.
    Kaur A; Kassis N; Hale CL; Simon M; Elliott M; Gomez-Yafal A; Lifson JD; Desrosiers RC; Wang F; Barry P; Mach M; Johnson RP
    J Virol; 2003 May; 77(10):5749-58. PubMed ID: 12719568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
    Lee H; Park KH; Ryu JH; Choi AR; Yu JH; Lim J; Han K; Kim SI; Yang CW; Chung BH; Oh EJ
    PLoS One; 2017; 12(12):e0189488. PubMed ID: 29232714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Utility of QuantiFERON-Cytomegalovirus Test in Management of Kidney Transplant Recipients.
    Tarasewicz A; Dębska-Ślizień A; Rutkowski B
    Transplant Proc; 2016 Jun; 48(5):1650-3. PubMed ID: 27496465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Lee SM; Kim YJ; Yoo KH; Sung KW; Koo HH; Kang ES
    Ann Lab Med; 2017 May; 37(3):277-281. PubMed ID: 28224776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preserved specific anti-viral T-cell response but associated with decreased lupus activity in SLE patients with cytomegalovirus infection.
    Wu CS; Chyuan IT; Chiu YL; Chen WL; Shen CY; Hsu PN
    Rheumatology (Oxford); 2020 Nov; 59(11):3340-3349. PubMed ID: 32306043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent skewing of the T cell and NK cell compartments associated with cytomegalovirus infection suggests division of labor between innate and adaptive immunity.
    Bengnér M; Béziat V; Ernerudh J; Nilsson BO; Löfgren S; Wikby A; Malmberg KJ; Strindhall J
    Age (Dordr); 2014 Apr; 36(2):571-82. PubMed ID: 24065293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant IFNγ responses of CD8+ T cells in CMV-seropositive individuals with autoimmune arthritis.
    Almanzar G; Schmalzing M; Trippen R; Höfner K; Weißbrich B; Geissinger E; Meyer T; Liese J; Tony HP; Prelog M
    J Clin Virol; 2016 Apr; 77():77-84. PubMed ID: 26921739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
    Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.